Your session is about to expire
← Back to Search
Rectus Sheath Block for Postoperative Pain After Cardiac Surgery
N/A
Waitlist Available
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Scheduled to undergo cardiac procedures involving chest tubes
Adults 18-85 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 72 hours
Awards & highlights
Study Summary
This trial will test if a nerve block can reduce post-op pain & opioid use after cardiac surgery.
Who is the study for?
This trial is for adults aged 18-85 scheduled for cardiac surgery that involves chest tubes. It's not suitable for those with severe systemic disease (ASA class V), urgent surgeries, allergies to local anesthesia, inability to consent, or a history of substance abuse or chronic opioid use.Check my eligibility
What is being tested?
The study is testing if a nerve block called Rectus Sheath Block can reduce pain and the need for opioids after heart surgery. Participants are randomly chosen to either receive this block or no block at all to compare outcomes.See study design
What are the potential side effects?
While specific side effects aren't listed here, generally speaking, potential side effects from rectus sheath blocks may include discomfort at the injection site, bleeding, infection risk and rarely nerve damage.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for a heart procedure that will use chest tubes.
Select...
I am between 18 and 85 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 72 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~72 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Opioid consumption
VAS pain scores
Secondary outcome measures
Length of hospital stay
Length of stay in ICU
Time to extubation
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Rectus Sheath BlockExperimental Treatment1 Intervention
Group II: No blockActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Rectus sheath block
2018
N/A
~260
Find a Location
Who is running the clinical trial?
Icahn School of Medicine at Mount SinaiLead Sponsor
858 Previous Clinical Trials
524,086 Total Patients Enrolled
3 Trials studying Postoperative Pain
224 Patients Enrolled for Postoperative Pain
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am unable or unwilling to give consent for treatment.You are classified as ASA class V.I need surgery urgently or as an emergency.I am scheduled for a heart procedure that will use chest tubes.I am between 18 and 85 years old.I am allergic to or cannot have local anesthesia.You have a history of using drugs or regularly taking opioids.I am either male or female.
Research Study Groups:
This trial has the following groups:- Group 1: Rectus Sheath Block
- Group 2: No block
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are participants aged 20 or over being included in this experimental protocol?
"According to the prerequisites for this trial, participants must be aged 18 or over and no older than 85."
Answered by AI
To what demographic is enrollment in this clinical experiment open?
"To qualify for the trial, cardiovascular disease sufferers between 18 and 85 years old are invited to apply. It is estimated that 200 patients will be accepted into this clinical investigation."
Answered by AI
Is the trial currently open to new participants?
"According to records hosted on clinicaltrials.gov, the trial posted on May 15th 2023 is not presently recruiting patients. However, there are 466 other studies actively accepting enrollees at this time."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger